MTOR and ovarian carcinoma: Gene Ontology analysis of the 80 genes revealed interesting targets in relation to site of expression (e.g., ovarian cancer, cervical cancer and normal ovarian tissue), cellular components (primarily cytoplasm and nucleus), biological processes (e.g., signal transduction) and biological pathways (mainly mTOR and plasma membrane estrogen receptor signalling pathways).